A titan of vaccine development sees his field’s achievements slip away

Stanley Plotkin vividly remembers a tragic night in 1957 during his pediatrics internship at Cleveland Metropolitan General Hospital. A distraught father brought in his gravely ill toddler who was struggling to breathe. Despite his best efforts, Plotkin was unable to save the 3-year-old boy, who had succumbed to Haemophilus influenzae type b, a dangerous bacterial infection.

Haemophilus influenzae type b, commonly known as Hib, can cause mild symptoms in some children but can lead to severe systemic diseases like meningitis, pneumonia, and sepsis in others. In the case of the toddler Plotkin encountered, the infection had caused swelling of the epiglottis, the flap at the base of the tongue that helps prevent food from entering the airways.

This heartbreaking experience left a lasting impact on Plotkin and fueled his passion for pediatric infectious diseases. Over the years, he has dedicated his career to developing vaccines to prevent deadly diseases like Hib. Thanks to his pioneering work, vaccines for Hib have become a standard part of childhood immunization schedules, saving countless lives around the world.

Plotkin’s story serves as a powerful reminder of the importance of vaccination in preventing devastating diseases. By ensuring that children receive all recommended vaccines, we can protect them from potentially life-threatening infections and create a safer, healthier future for generations to come.

As we reflect on Plotkin’s experience and the impact of his work, we are reminded of the critical role that vaccines play in public health. By continuing to invest in research and development of new vaccines, we can build upon Plotkin’s legacy and work towards a world free of preventable diseases.